Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 1999, p. 1260-1263, Vol. 43, No. 5
Mycology Reference Laboratory, Public Health
Laboratory Service, Bristol BS2 8EL, United Kingdom
Received 19 October 1998/Returned for modification 14 December
1998/Accepted 10 February 1999
The in vitro activity of Syn-2869 was compared with that
of amphotericin B and itraconazole. MICs for 100 isolates of pathogenic molds belonging to 12 species were determined by a broth microdilution adaptation of the method recommended by the National Committee for
Clinical Laboratory Standards. Syn-2869 and itraconazole
showed comparable, good activity against the dematiaceous molds
Cladophialophora bantiana, Cladophialophora
carrionii, Exophiala dermatitidis, Fonsecaea
pedrosoi, Phialophora parasitica, and
Ramichloridium mackenziei. Neither of the azole agents was
active against the hyaline molds Fusarium solani,
Scedosporium prolificans, and Scopulariopsis brevicaulis, but both were more active than amphotericin B
against Scedosporium apiospermum. The MICs
of the three agents were comparable for the mucoraceous mold
Absidia corymbifera, but Syn-2869 appeared to be
the least active against the dimorphic mold Sporothrix
schenckii. Our results suggest that Syn-2869 could be
effective against a range of mold infections in humans.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
In Vitro Activity of Syn-2869, a Novel Triazole
Agent, against Emerging and Less Common Mold Pathogens
*
Corresponding author. Mailing address: Mycology
Reference Laboratory, Public Health Laboratory, Kingsdown,
Bristol BS2 8EL, United Kingdom. Phone: (44) 117-928-5031. Fax: (44)
117-922-6611.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»